NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
118 hedge funds and large institutions have $1B invested in NxStage Medical Inc. in 2014 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 34 increasing their positions, 36 reducing their positions, and 15 closing their positions.
60% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 15
39% more capital invested
Capital invested by funds: $721M → $1B (+$280M)
10% more call options, than puts
Call options by funds: $22K | Put options by funds: $20K
6% more funds holding
Funds holding: 111 → 118 (+7)
6% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 36
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$40.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$24.1M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$11.3M |
| 4 |
O
OppenheimerFunds
New York
|
+$10.8M |
| 5 |
CM
Castleark Management
Chicago,
Illinois
|
+$9.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$21.4M |
| 2 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$16.7M |
| 3 |
William Blair & Company
Chicago,
Illinois
|
-$15.8M |
| 4 |
APG Asset Management
Amsterdam,
Netherlands
|
-$11M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.21M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PSC
126
Piper Sandler & Co
Minneapolis,
Minnesota
| – | -$423K | -32,200 | Closed |
|
|
BACM
127
Blue Arrow Capital Management
New York
| – | -$263K | -20,000 | Closed |
|
|
PA
128
Perceptive Advisors
New York
| – | -$263K | -20,000 | Closed |
|
129
Jane Street
New York
| – | -$205K | -15,589 | Closed |
|
|
TMC
130
Trellus Management Company
Delray Beach,
Florida
| – | -$201K | -15,311 | Closed |
|
131
Credit Agricole
Montrouge Cedex,
France
| – | -$150K | -11,386 | Closed |
|
132
BNP Paribas Financial Markets
Paris,
France
| – | -$48.7K | -3,711 | Closed |
|
|
PFO
133
Pathstone Family Office
Englewood,
New Jersey
| – | -$2K | -172 | Closed |
|
NXTM Hedge Fund Activity: Q4 2014 in Review
118 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q4 2014, worth a combined $1B — up 39% from $721M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new NXTM positions and 15 closed out — a net gain of 9 holders — while 34 added to existing stakes and 36 trimmed.
The largest buyer was Lord, Abbett & Co, adding an estimated $40.6M. The largest seller was Deerfield Management, cutting an estimated $21.4M.
- 118 institutional investors held NxStage Medical Inc. (NXTM) as of Q4 2014, up from 111 in Q3 2014.
- Funds reported $1B of NxStage Medical Inc. stock for Q4 2014, up 39% quarter-over-quarter.
- 24 funds opened new NxStage Medical Inc. positions in Q4 2014 and 15 closed out, a net change of +9 holders.
- The largest NxStage Medical Inc. buyer in Q4 2014 was Lord, Abbett & Co, an estimated $40.6M added.
- The largest NxStage Medical Inc. seller in Q4 2014 was Deerfield Management, an estimated $21.4M sold.
Based on aggregated 13F filings for Q4 2014.